Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

car-t

car-t is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 8
Pipeline programs 110
News articles 0
Drug details — car-t
Class
—
Route
—
Patents
8
Programs
110
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

car-t is an FDA-listed pharmaceutical active ingredient.

Key facts

INN car-t

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. CA088-1007 Phase 3 · Celgene · Relapsed or Refractory and Lenalidomide exposed Multiple Mye
  2. CCTL019A2205B Phase 3 · Novartis India · All patients who have been treated with Novartis or Penn CAR
  3. GLPG CAR T-cell therapy Phase 3 · Lakefront Biotherapeutics NV · Hematological Malignancies
  4. ARI-HER2 Phase 2 · George Institute for · Patients with HER2Positive Advanced Breast Cancer
  5. AUTO CAR T cell therapy Phase 2 · Autolus · Patients Followed for up to 15 Years Following Their First D
  6. AUTO-LT1 Phase 2 · Autolus · Potential malignancy in patients who received treatment with
  7. AUTO3 (CD19/22 CAR T cells Phase 2 · Autolus · B Acute Lymphoblastic Leukemia
  8. Autologous BCMA-targeting CAR T cells Phase 2 · Chinese Academy of · Multiple Myeloma in Relapse

Related patents

Browse patents

  1. US 12295362

    Formulations and processes for CAR T cell drug products

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12187780

    Car t-cells comprising inactivated CBL and CBL-B genes

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11987628

    Methods and compositions for modulating CAR-T activity

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11965022

    Methods and compositions for modulating CAR-T activity

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11851672

    CAR T-cells comprising transcriptional circuits

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11819571

    Micelle constructs comprising curcumin

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11802157

    Methods and compositions for modulating CAR-T activity

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9833508

    Cancer therapeutics

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is car-t?

car-t is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.